Internal Medicine, Gastroenterology · Anderson, IN
NPI
1821179714
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1601 Medical Arts Blvd, Suite 102
Anderson, IN, 46011
Phone (765) 298-4720
Groups this clinician bills Medicare through
Medicare paid, 2024
$101K
1,399 services
Medicare patients, 2024
534
Average age 74
Drug cost, 2024
$1.4M
2,119 prescriptions
Company payments, 2025
$1,514
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roderick Nisi was code G0500 (moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito), 329 times for 296 patients. In total Roderick Nisi billed 1,399 services in 48 codes, and Medicare paid $101K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 329 | 296 | $3.51 | $1,155 |
| 99213 Office E&M - Established | Office | 269 | 186 | $58.35 | $16K |
| 45385 Colonoscopy - Lesion Removal | Facility | 141 | 138 | $186.59 | $26K |
| 43239 Upper GI Endoscopy | Facility | 112 | 100 | $71.21 | $7,976 |
| 43235 Upper GI Endoscopy | Facility | 58 | 56 | $70.60 | $4,095 |
| 43450 Digestive/Gastrointestinal | Facility | 52 | 49 | $28.09 | $1,461 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 46 | 45 | $162.27 | $7,464 |
| 99232 Hospital E&M - Subsequent | Facility | 45 | 22 | $53.49 | $2,407 |
| 99204 Office E&M - New | Office | 43 | 43 | $82.96 | $3,567 |
| 45380 Lower GI Endoscopy - Other | Facility | 43 | 42 | $101.37 | $4,359 |
| 99203 Office E&M - New | Office | 41 | 41 | $68.22 | $2,797 |
| 99214 Office E&M - Established | Office | 40 | 37 | $79.65 | $3,186 |
| 45378 Lower GI Endoscopy - Other | Facility | 35 | 34 | $121.55 | $4,254 |
| 43248 Upper GI Endoscopy | Facility | 20 | 16 | $115.14 | $2,303 |
| 99221 Hospital E&M - Initial | Facility | 16 | 16 | $60.46 | $967 |
By year: 2022 $117K for 1,649 services; 2023 $103K for 1,449 services; 2024 $101K for 1,399 services.
Medicare prescription drug claims, 2024
In 2024, the drug Roderick Nisi prescribed most often to Medicare patients was Omeprazole, with 640 prescriptions and refills. In total Roderick Nisi wrote 2,119 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 640 | 1,383 | 192 | $8,784 |
| Pantoprazole Sodium Generic | 143 | 317 | 44 | $2,575 |
| Linzess Linaclotide | 113 | 189 | 43 | $99K |
| Ondansetron Odt Ondansetron | 81 | 83 | 29 | $1,683 |
| Mesalamine Er Mesalamine | 76 | 127 | 22 | $20K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 72 | 84 | 23 | $1,860 |
| Esomeprazole Magnesium Generic | 64 | 153 | 20 | $5,092 |
| Dicyclomine Hcl Generic | 57 | 127 | 23 | $1,314 |
| Famotidine Generic | 54 | 130 | 20 | $772 |
| Metoclopramide Hcl Generic | 54 | 54 | 34 | $67.47 |
| Lubiprostone Generic | 45 | 85 | 12 | $8,691 |
| Lansoprazole Generic | 33 | 70 | 17 | $649 |
| Loperamide Loperamide Hcl | 32 | 50 | Under 11 | $1,174 |
| Ondansetron Hcl Generic | 31 | 31 | 18 | $1,628 |
| Azathioprine Generic | 30 | 69 | Under 11 | $1,489 |
Brand drugs: - claims; generic drugs: 1,744 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roderick Nisi $1,514 ($1,514 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $449.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 24 | $449 |
| Janssen Biotech, Inc. JNJ | 12 | $317 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 15 | $219 |
| QOL Medical, LLC | 5 | $98.21 |
| Gilead Sciences, Inc. GILD | 3 | $71.42 |
| Lilly USA, LLC LLY | 3 | $55.88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $55.34 |
| Vivus LLC | 2 | $41.78 |
| Pfizer Inc. PFE | 2 | $40.25 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $38.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.